INTRINSIC HEALTH PARTNERS II, L.P.
Open, writing first checksEmerging manager
Open: first sale Dec 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $62.37M (Form D)
- Stages
- Growth
- Sectors
- Not stated
- Regions
- Not stated
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$2.08M to $3.9M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Christopher Jung, Chief Financial Officer of Issuer's General Partner
- Cornelius Merlini, Managing Member of Issuer's General Partner
- Gerald Stahlecker III, Managing Member of Issuer's General Partner
- Howard Goodwin M.D., Managing Member of Issuer's General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideGrowth-equity investment firm focused on scalable life science and technology-focused businesses within the alternative therapeutics market.
With a focus on growth-equity stage businesses across the supply chain, Intrinsic Capital Partners employs an operator-centric investment model
https://www.intrinsiccapitalpartners.com/about
06 · Sources
Last verified: Oct 28, 2026